Stem Cells and Regenerative Medicine
Regenerative medicine is a relatively new field of study that heals or replaces tissues and organs damaged by age, disease, or trauma, as well as to ameliorate congenital defects. Recent promising preclinical and clinical data supports the possibility for treating both chronic and acute diseases. Regenerative medicine is also able to abet diseases occurring across a wide array of organ systems, including cardiovascular diseases and traumas, skin diseases, treatments for certain types of cancer, and so on. One of the aims of regenerative sciences is to create new body parts from a patient’s own cells and tissues. This would serve two functions: eliminate the demand for organs; and eliminate the complications due to organ rejection. When there is damage to tissues or organs, they could repair themselves with pluripotent stem cells; this process could reverse or prevent damage to vital organs.
- Embryonic Stem cells
- Stem Cell Biomarkers
- Rehabilitation Engineering
- Genetically modified Stem Cell Therapy
- Regenerative Medicine for Tissue Regeneration
Related Conference of Stem Cells and Regenerative Medicine
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stem Cells and Regenerative Medicine Conference Speakers
Recommended Sessions
- Animal Biotechnology
- Applied Biotechnology
- Biochemistry
- Bioinformatics
- Cancer Biotechnology
- Cell Biology
- CRISPR-Cas 9 and Gene Editing
- Gene and Cellular Therapies
- Genetic Engineering
- Genomics
- Immunology
- Industrial and Environmental Biotechnology
- Metabolic Engineering
- Microbiology
- Molecular Biology and Genetics
- Nanobiotechnology
- Plant Biotechnology
- Protein Engineering
- Stem Cells and Regenerative Medicine
- Tissue Engineering
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)